Pegylated interleukin-2 (PharmaEssentia Corporation)

N/A

Report date: 2026/01/08 11:08:06

Base Information

Drug NamePegylated interleukin-2 (PharmaEssentia Corporation)
Drug Alias NamePEG-IL-2(PharmaEssentia Corporation)P11838P-11838
ClassificationBiologics
Mechanisms of ActionInterleukin-2 replacements
TargetsInterleukin-2
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A